Testing MOON101 Safety for Peanut Allergy Treatment
Part of Immune system & allergy clinical trials.
This study tests whether a new drug called MOON101 is safe for people with peanut allergies. The goal is to see if it might help your immune system tolerate peanuts better and reduce severe allergic reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 4 and 55 years old
- You have a confirmed peanut allergy (reaction within 2 hours of eating peanuts)
- You have not used peanut allergy treatments in the past 6 months
- You have no liver or kidney disease
- Your asthma (if you have it) is well-controlled
- You are not currently taking certain blood pressure or heart medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.